-
Ipilimumab plus nivolumab and chemoradiotherapy followed by surgery in patients with resectable and borderline resectable T3-4N0-1 non-small cell lung cancer: The INCREASE trial
Dickhoff, C., Senan, S., Schneiders, F. L., Veltman, J., Hashemi, S., Daniels, J. M. A., Fransen, M., Heineman, D. J., Radonic, T., van de Ven, P. M., Bartelink, I. H., Meijboom, L. J., Garcia-Vallejo, J. J., Oprea-Lager, D. E., de Gruijl, T. D. & Bahce, I., 14 Aug 2020, In: BMC cancer. 20, 1, 764.Research output: Contribution to journal › Article* › Academic › peer-review
- All publications
